Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...
Alzheimer’s disease is a long, slow neurodegenerative calamity, and scientists are still hunting for blood biomarkers that reflect all its specific stages. At the Clinical Trials on Alzheimer’s ...
Rosa-Grilo incorporated Wave-CAIPI into the diagnostic scanning protocol used at UCL’s memory clinic. It comprises four sequences: T1-weighted 3D, T2-weighted 2D, T2-weighted 3D, and 3D FLAIR imaging.
Mivelsiran docks APP products in early AD. Phase 2 trial asks: Can it treat CAA? LX1001 gene therapy boosts CSF ApoE2, stabilizes AD biomarkers. Intranasal insulin quells systemic inflammation. These ...
Rosa-Grilo incorporated Wave-CAIPI into the diagnostic scanning protocol used at UCL’s memory clinic. It comprises four sequences: T1-weighted 3D, T2-weighted 2D, T2-weighted 3D, and 3D FLAIR imaging.
MD - University of North Carolina MBA - Kenan-Flagler Business School @ UNC MS Neuroscience - Tulane University Radiology Residency - Weill Cornell Fellowship Neuroradiology - Massachusetts General ...
Applications may request budgets of up to $100,000 in direct costs per year for up to two years.
Direct costs limited to $225,000 per year and $450,000 over the 3-year project period.
Award budgets are composed of salary and additional expenses. NIH will fund up to $42,500 per year in salary. NIH will fund up to $28,656 for additional expenses such as fringe benefits (e.g., health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback